« Aumenta la construcción en EE.UU. | Inicio | Inflation woes heighten investors’ uncertainty »
Pharmacopeia Ups Investors’ Blood Pressure
By Anita Broker | May 16, 2008
Investors flock to the stock over positive results for the company’s blood pressure treatment.
forbes.com/markets/2008/05/16/pharmacopeia-hypertension-trials-ma
Categoría: Forbes: Markets News |